Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
The Technology Select Sector SPDR® Fund
XLK
4
Invesco Solar ETF
TAN
5
Invesco DB Commodity Index Tracking Fund
DBC
US Stock MarketDetailed Quotes
Korro Bio (KRRO)
- 11.220
- -0.240-2.09%
Close May 12 16:00 ET
- 11.220
- 0.0000.00%
Post 16:27 ET
161.82MMarket Cap-0.96P/E (TTM)
11.565High10.890Low118.09KVolume11.410Open11.460Prev Close1.32MTurnover1.23%Turnover RatioLossP/E (Static)14.42MShares55.89052wk High1.35P/B107.50MFloat Cap5.20452wk Low--Dividend TTM9.58MShs Float2918.500Historical High--Div Yield TTM5.89%Range %5.204Historical Low11.159Avg Price1Lot Size
KRRO Stock Chart
After-Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
KRRO Orderflow
Unit: --
KRRO Orderflow Trend
IntradayDayWeekMonth
No Data
Korro Bio (KRRO) News
JonesTrading Upgrades Korro Bio(KRRO.US) to Buy Rating, Announces Target Price $23
Korro Bio (KRRO) Receives a Hold From RBC Capital
Chardan Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15
Analysts Have Conflicting Sentiments on These Healthcare Companies: CareCloud (CCLD) and Korro Bio (KRRO)
Korro Bio Reports Q1 EPS ($1.69), Consensus ($1.98)
Express News | Korro Bio Inc - Reports Cash, Cash Equivalents and Marketable Securities of $157.1 Mln as of March 31, 2026
Korro Bio (KRRO) Stock Forum
$Korro Bio (KRRO.US)$
Korro Announces Oversubscribed $85 Million Private Placement
by Globe Newswire
Follow
Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors
Proceeds support the achievement of value inflection points for multiple RNA editing programs including reporting clinical data for:
KRRO-121 for hyperammonemia in patients with urea cycle disorders
Korro's GalNAc-conjugated oligonucleotide intended for patients wit...
Korro Announces Oversubscribed $85 Million Private Placement
by Globe Newswire
Follow
Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors
Proceeds support the achievement of value inflection points for multiple RNA editing programs including reporting clinical data for:
KRRO-121 for hyperammonemia in patients with urea cycle disorders
Korro's GalNAc-conjugated oligonucleotide intended for patients wit...
$Korro Bio (KRRO.US)$ this will go to 9+ by next week 👀👀
3
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)